With everything from analysts lowering estimates to the political cycle to a very hard to follow Federal Reserve, the ingredients are there for a witches brew of volatility.
All these companies have faced issues. However, investors that bought and held shares over time did very well on a total return basis.
St. Jude Medical has issued a press release aimed at responding to points in the Muddy Waters report, and a Credit Suisse research report has dispelled some of the concerns.
Jon C. Ogg Here are eight well-known stocks with either unusual or massive gains seen in their short interest as of the May 13, 2016, settlement date.
The top analyst upgrades, downgrades and initiations seen on Wednesday morning include Baidu, Enterprise Products Partners, Kinder Morgan, Kinross Gold, Marketo, Office Depot, Staples, Walt Disney, Williams Companies.
Investors love when companies pay dividends. More specifically, they love companies that are raising their dividends year after year.
Top analyst upgrades, downgrades and initiations seen Thursday morning include Abbott Labs, American Express, Apple, Citrix, ConocoPhillips, Kinder Morgan, Qualcomm, ServiceNow and Tesla Motors.
With investors looking for safety and dividends for total return, the big pharmaceutical stocks are just the ticket, and these four are outstanding.
Alere absolutely skyrocketed in Monday’s regular session following the announcement that it will be acquired by Abbott Laboratories.
Chris Lange January 28, 2016: Here are four stocks trading with heavy volume among 222 equities making new 52-week lows today. Juniper Networks Inc. (NYSE: JNPR) dropped more than 17% on Thursday to post…
Thursday's top analyst calls include Alcoa, GoPro, MetLife, Netflix, SUPERVALU, Walt Disney, Williams Companies and Yelp.
One good plan for stockholders who are seeing gains evaporate is to rotate to a more defensive sector. Large cap pharmaceutical stocks totally fit the bill.
These companies all provide drugs and medical devices that help hundreds of thousands of people daily lead a better life. They make good sense for conservative portfolios looking for income and growth…
In what still may be a pricey market, these stock make good sense for growth accounts looking to add value, and they are far safer than high-volatility momentum stocks.
Brokerage firm Jefferies has released its top pharmaceutical picks for the coming year and what to expect.
